Perbedaan Griptha Putra Persada Tbk. dan Merck Tbk.: Griptha Putra Persada Tbk. diperdagangkan di Rp59 (kapitalisasi pasar 60 M, volume 24 jam 661,3 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 28× kapitalisasi pasar Griptha Putra Persada Tbk., dan Griptha Putra Persada Tbk. lebih aktif diperdagangkan (661,3 rb vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| GRPH | MERK | |
|---|---|---|
Kapitalisasi Pasar | 60 M | 1,68 T |
Volume | 661,3 rb | 33,3 rb |
Lot | 6,61 rb | 333 |
Perputaran | 39,67 jt | 126,46 jt |
Harga Rata-rata | 59,99 | 3.797,72 |
Nilai Transaksi | 39,67 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 59 | 3.800 |
Volume Ekuilibrium Indikatif | 640 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Selengkapnya di halaman GRPH →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →